NGM Biopharmaceuticals is a biopharmaceutical company that focuses on developing therapeutic solutions for liver, metabolic, retinal diseases, and cancer. They currently have several product candidates under development and have research collaborations and license agreements with Merck Sharp & Dohme Corp. and Merck & Co., Inc. NGM Biopharmaceuticals was founded in 2007, and their headquarters are located in South San Francisco, California.